Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 18/20 | 0.50 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 1/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.40 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31228253 | 0.88 | ADK (0.51) | ADKDOT1LNPC1GALR3S1PR4 | |
| SCHEMBL31228437 | 0.87 | ADK (0.50) | ADKDOT1LNPC1GALR3S1PR4 | |
| SCHEMBL31228230 | 0.85 | ADK (0.48) | ADKDOT1LNPC1GALR3S1PR4 | |
| SCHEMBL31228211 | 0.85 | ADK (0.59) | ADKDOT1LNPC1GALR3S1PR4 | |
| SCHEMBL31228248 | 0.84 | ADK (0.60) | ADKDOT1LNPC1GALR3S1PR4 | |
| SCHEMBL13844404 | 0.81 | PRMT5 (0.61) | DOT1LPRMT5WDR77 | |
| SCHEMBL31725296 | 0.79 | PRMT5 (0.47) | ADKDOT1LNPC1GALR3S1PR4 | |
| SCHEMBL31228198 | 0.77 | ADK (0.57) | ADKPRMT5WDR77 | |
| SCHEMBL6685798 | 0.76 | ADK (0.71) | ADKDOT1LNPC1GALR3S1PR4 | |
| SCHEMBL31228272 | 0.74 | PRMT5 (0.39) | ADKPRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |